Rodberg James, CFO of Sight Sciences, Inc. ($SGHT), made four open market sales of company shares in the last year, totaling nearly $77,000. His latest sale occurred on January 16, 2026. These transactions rank 9,927th among 11,678 insiders in our database, far below the average sale value of $8.6 million across 6.4 trades. Rodberg James reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | Sight Sciences, Inc. | $SGHT | Rodberg James | Chief Financial Officer | A | Common Stock | 86940 | $0.00 | 238,170.0000 | 52,871,731 | 57.49% | 0.16% |
| Jan. 16, 2026 | Sight Sciences, Inc. | $SGHT | Rodberg James | Chief Financial Officer | S | Common Stock | 2616 | $6.62 | 151,230.0000 | 52,871,731 | 1.70% | 0.00% |
| Jan. 5, 2026 | Sight Sciences, Inc. | $SGHT | Rodberg James | Chief Financial Officer | S | Common Stock | 4405 | $7.82 | 154,440.0000 | 52,871,731 | 2.77% | 0.01% |
| Jan. 6, 2026 | Sight Sciences, Inc. | $SGHT | Rodberg James | Chief Financial Officer | S | Common Stock | 594 | $7.48 | 153,846.0000 | 52,871,731 | 0.38% | 0.00% |
| Dec. 2, 2025 | Sight Sciences, Inc. | $SGHT | Rodberg James | Chief Financial Officer | S | Common Stock | 2518 | $8.25 | 158,845.0000 | 52,871,731 | 1.56% | 0.00% |
| Nov. 11, 2025 | Sight Sciences, Inc. | $SGHT | Rodberg James | Chief Financial Officer | A | Common Stock | 15337 | $0.00 | 161,363.0000 | 52,871,731 | 10.50% | 0.03% |
| March 16, 2023 | Sight Sciences, Inc. | $SGHT | Rodberg James | See Remarks | A | Common Stock | 20600 | $0.00 | 699.0000 | 0 | 0.00% | 0.00% |
| March 16, 2023 | Sight Sciences, Inc. | $SGHT | Rodberg James | See Remarks | A | Stock Option (Right to Buy) | 14400 | $0.00 | 14,400.0000 | 0 | 9999.99% | 0.00% |